These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6691892)

  • 1. Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
    Van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
    Br J Clin Pharmacol; 1984 Jan; 17(1):86-8. PubMed ID: 6691892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipid fractions during bopindolol treatment in hypertensive patients.
    van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S42-4. PubMed ID: 2439818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
    van Brummelen P; Bühler FR; Amann FW; Bolli P
    Eur J Clin Pharmacol; 1982; 22(6):491-3. PubMed ID: 6127218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
    Andersson OK; Hedner T; Nyberg G
    Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
    Weidmann P; Bousquet JC
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S80-7. PubMed ID: 2439828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-finding study with bopindolol in arterial hypertension.
    Willimann P; Peter R; Siegenthaler H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age.
    Hulthén UL; van Brummelen P; Amann FW; Bühler FR
    J Cardiovasc Pharmacol; 1983; 5(3):426-9. PubMed ID: 6191141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
    J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of atenolol and bopindolol on circadian heart rate.
    Fitscha P; Meisner W; Tiso B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S51-4. PubMed ID: 2439821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
    Favre L; Adamec R; Boxho G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Schiess W; Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
    Yamashita K; Shigematsu K; Maeda T; Ishida Y; Niwa M; Ozaki M
    Nihon Yakurigaku Zasshi; 1989 Jan; 93(1):7-15. PubMed ID: 2565861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
    Fitscha P; Meisner W; Brandstetter G; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity.
    Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
    Román O; Pino ME; Valenzuela A
    Cardiology; 1987; 74(3):219-25. PubMed ID: 3594511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.